Strategic Developments in the 2026 STDs Diagnostic Market: Molecular Multiplexing, POC Integration, and Public Health Surveillance
As of February 2026, the global diagnostic landscape is witnessing a structural transition in the management of infectious pathologies, with the Sexually Transmitted Diseases Diagnostic Market moving toward high-sensitivity molecular platforms and decentralized testing. The maturation of Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) has enabled clinicians to provide...
0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior